References
- Anon JB. Upper respiratory infections. Am J Med 2010;123:S16–525
- Halawi AM, Smith SS, Chandra RK. Chronic rhinosinusitis: epidemiology and cost. Allergy Asthma Proc 2013;34:328–334
- Scadding GK, Durham SR, Mirakian R, et al. BSACI guidelines for the management of rhinosinusitis and nasal polyposis. Clin Exp Allergy 2008;38:260–275
- Rosenfeld RM, Andes D, Bhattacharyya N, et al. Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg 2007;137:S1–S31
- Chung S-D, Hung S-H, Lin H-C, Lin C-C. Health care service utilization among patients with chronic rhinosinusitis: population-based study. Laryngoscope 2014;124:1285–1289
- Hung SH, Chen PY, Lin HC, et al. Association of rhinosinusitis with nasopharyngeal carcinoma: a population-based study. Laryngoscope 2014;124(7):1515--1520
- Marks MB. Allergic shiners. Dark circles under the eyes in children. Clin Pediatr (Phila) 1966;5:655–658
- Ranu H, Thng S, Goh BK, et al. Periorbital hyperpigmentation in Asians: an epidemiologic study and a proposed classification. Dermatol Surg 2011;37:1297–1303
- Chung SD, Lin HC, Hung SH. Allergic rhinitis is associated with open-angle glaucoma: a population-based case-control study. Am J Rhinol Allergy 2014;28(4):148–151
- Cyriac JT, Cherian T, Hadi WA, Jose J. Optic neuropathy due to allergic fungal rhinosinusitis. J Neurosci Rural Pract 2011;2:180–182
- Kang JH, Chen YH, Lin HC. Comorbidity profiles among patients with ankylosing spondylitis: a nationwide population-based study. Ann Rheum Dis 2010;69:1165–1168
- Cheng CL, Kao YH, Lin SJ, et al. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 2011;20:236–242
- Hsieh C-Y, Chen C-H, Li C-Y, Lai M-L. Validating the diagnosis of acute ischemic stroke in a National Health Insurance claims database. Bull World Health Organ 1995;73(1):115--121
- Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY. Global data on blindness. J Formosan Med Ass 2013. doi:10.1016/j.jfma.2013.09.009. [Epub ahead of print]
- Nelson LB, Calhoun JH, Simon JH, Harley RD. Progression of congenital anterior polar cataracts in childhood. Arch Ophthalmol 1985;103:1842–1843
- West SK, Valmadrid CT. Epidemiology of risk factors for age-related cataract. Surv Ophthalmol 1995;39:323–334
- Lindblad BE, Hakansson N, Philipson B, Wolk A. Metabolic syndrome components in relation to risk of cataract extraction: a prospective cohort study of women. Ophthalmology 2008;115:1687–1692
- Bhattacharyya N. Incremental healthcare utilization and expenditures for allergic rhinitis in the United States. Laryngoscope 2011;121:1830–1833
- Bhattacharyya N. Incremental health care utilization and expenditures for chronic rhinosinusitis in the United States. Ann Otol Rhinol Laryngol 2011;120:423–427
- Ornek K, Karel F, Buyukbingol Z. May nitric oxide molecule have a role in the pathogenesis of human cataract? Exp Eye Res 2003;76(1):23--27
- Ito Y, Nabekura T, Takeda M, et al. Nitric oxide participates in cataract development in selenite-treated rats. Curr Eye Res 2001;22(3):215--220
- Djupesland PG, Chatkin JM, Qian W, Haight JS. [Nitric oxide in the nose and paranasal sinuses – respiratory tract physiology in a new perspective]. Tidsskr Nor Laegeforen 1999;119:4070–4072
- Bommarito L, Guida G, Heffler E, et al. Nasal nitric oxide concentration in suspected chronic rhinosinusitis. Ann Allergy Asthma Immunol 2008;101:358–362
- Guida G, Rolla G, Badiu I, et al. Determinants of exhaled nitric oxide in chronic rhinosinusitis. Chest 2010;137:658–664
- Takeno S, Taruya T, Ueda T, et al. Increased exhaled nitric oxide and its oxidation metabolism in eosinophilic chronic rhinosinusitis. Auris Nasus Larynx 2013;40:458–464
- Deroee AF, Naraghi M, Sontou AF, et al. Nitric oxide metabolites as biomarkers for follow-up after chronic rhinosinusitis surgery. Am J Rhinol Allergy 2009;23:159–161
- Toda N, Nakanishi-Toda M. Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy. Prog Retin Eye Res 2007;26:205–238
- James ER. The etiology of steroid cataract. J Ocul Pharmacol Ther 2007;23:403–420
- Kosano H, Nishigori H. Steroid-induced cataract: other than in the whole animal system, in the lens culture system, androgens, estrogens and progestins as well as glucocorticoids produce a loss of transparency of the lens. Dev Ophthalmol 2002;35:161–168
- Cumming RG, Mitchell P, Leeder SR. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med 1997;337:8–14
- Jick SS, Vasilakis-Scaramozza C, Maier WC. The risk of cataract among users of inhaled steroids. Epidemiology 2001;12:229–234
- Barenholtz H. Effect of inhaled corticosteroids on the risk of cataract formation in patients with steroid-dependent asthma. Ann Pharmacother 1996;30:1324–1327
- Miller DP, Watkins SE, Sampson T, Davis KJ. Long-term use of fluticasone propionate/salmeterol fixed-dose combination and incidence of cataracts and glaucoma among chronic obstructive pulmonary disease patients in the UK General Practice Research Database. Int J Chron Obstruct Pulmon Dis 2011;6:467–476
- Derby L, Maier WC. Risk of cataract among users of intranasal corticosteroids. J Allergy Clin Immunol 2000;105:912–916
- LaForce C, Journeay GE, Miller SD, et al. Ocular safety of fluticasone furoate nasal spray in patients with perennial allergic rhinitis: a 2-year study. Ann Allergy Asthma Immunol 2013;111:45–50